Summary
In three weeks, the Government will reclassify cannabis from a class B to a class C drug, which will cut the maximum penalty connected with it, and in keeping with this spirit of liberalisation an AAA-rated shrewd investor has been secretly dealing in GW Pharmaceuticals'shares.
GW floated in 2001 and is the first listed firm to produce cannabis for medical purposes. It develops medicines for treating many ailments, including cancer. The company is well on its way to securing regulatory approval.The key to success will be its distribution partnerships. It appears to be off to a good start with these, too.See the full content of this document
Extract
Evershed Scores with Gw ; Secret Dealings
Canny investors have backed the...
See the full content of this document
Sponsored links
